Literature DB >> 18618130

Distribution of prolyl oligopeptidase in the mouse whole-body sections and peripheral tissues.

Timo T Myöhänen1, Jarkko I Venäläinen, J Arturo García-Horsman, Marjo Piltonen, Pekka T Männistö.   

Abstract

Prolyl oligopeptidase (POP) is a serine endopeptidase that hydrolyses proline-containing peptides shorter than 30-mer, including many bioactive peptides. The distribution of POP in the brain has been studied but little is known about the distribution of peripheral POP. We used immunohistochemistry to localize POP in mouse whole-body sections and at the cellular level in peripheral tissues. Furthermore, we used a POP activity assay to reveal the associations between POP protein and its enzymatic activity. The highest POP protein densities were found in brain, kidney, testis and thymus, but in the liver the amounts of POP protein were small. There were remarkable differences between the distribution of POP protein and activity. The highest POP activities were found in the liver and testis while kidney had the lowest activity. In peripheral tissues, POP was present in various cell types both in the cytoplasm and nucleus of the cells, in contrast to the brain where no nuclear localization was detected. These findings support the proposed role of POP in cell proliferation in peripheral tissues. The dissociation of the distribution of POP protein and its enzymatic activity points to nonhydrolytic functions of POP and to strict endogenous regulation of POP activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18618130     DOI: 10.1007/s00418-008-0468-x

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  53 in total

1.  Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain.

Authors:  K Toide; T Fujiwara; Y Iwamoto; M Shinoda; K Okamiya; T Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

Review 2.  Prolyl cis-trans isomerization as a molecular timer.

Authors:  Kun Ping Lu; Greg Finn; Tae Ho Lee; Linda K Nicholson
Journal:  Nat Chem Biol       Date:  2007-10       Impact factor: 15.040

Review 3.  On the role of prolyl oligopeptidase in health and disease.

Authors:  J A García-Horsman; P T Männistö; J I Venäläinen
Journal:  Neuropeptides       Date:  2006-12-29       Impact factor: 3.286

4.  Beneficial effect of prolyl oligopeptidase inhibition on spatial memory in young but not in old scopolamine-treated rats.

Authors:  Aaro J Jalkanen; Katja A Puttonen; Jarkko I Venäläinen; Veijo Sinervä; Anne Mannila; Sirja Ruotsalainen; Elina M Jarho; Erik A A Wallén; Pekka T Männistö
Journal:  Basic Clin Pharmacol Toxicol       Date:  2007-02       Impact factor: 4.080

5.  Distribution of prolyl endopeptidase activities in rat and human brain.

Authors:  Jon Irazusta; Gorka Larrinaga; Javier González-Maeso; Javier Gil; J Javier Meana; Luis Casis
Journal:  Neurochem Int       Date:  2002-04       Impact factor: 3.921

6.  Expression and localization of prolyl oligopeptidase in mouse testis and its possible involvement in sperm motility.

Authors:  Atsushi Kimura; Hitoshi Matsui; Takayuki Takahashi
Journal:  Zoolog Sci       Date:  2002-01       Impact factor: 0.931

7.  Transient up-regulation of a prolyl endopeptidase activity in the microsomal fraction of rat liver during postnatal development.

Authors:  Y Matsubara; T Ono; S Tsubuki; S Irie; S Kawashima
Journal:  Eur J Biochem       Date:  1998-02-15

8.  Regulation of prolyl oligopeptidase activity in regenerating rat liver.

Authors:  N Yamakawa; H Shimeno; S Soeda; A Nagamatsu
Journal:  Biochim Biophys Acta       Date:  1994-04-21

9.  A method for enzyme- and immunohistochemical staining of large frozen specimens.

Authors:  B Holmbom; M Lindström; U Näslund; L E Thornell
Journal:  Histochemistry       Date:  1991

10.  Subcellular distribution of prolyl endopeptidase and cation-sensitive neutral endopeptidase in rabbit brain.

Authors:  K Dresdner; L A Barker; M Orlowski; S Wilk
Journal:  J Neurochem       Date:  1982-04       Impact factor: 5.372

View more
  24 in total

Review 1.  State-of-the-art technologies, current opinions and developments, and novel findings: news from the field of histochemistry and cell biology.

Authors:  Esther Asan; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2008-11-05       Impact factor: 4.304

2.  Renal release of N-acetyl-seryl-aspartyl-lysyl-proline is part of an antifibrotic peptidergic system in the kidney.

Authors:  Cesar A Romero; Nitin Kumar; Pablo Nakagawa; Morel E Worou; Tang-Dong Liao; Edward L Peterson; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2018-11-07

3.  Tetrazole as a Replacement of the Electrophilic Group in Characteristic Prolyl Oligopeptidase Inhibitors.

Authors:  Tommi P Kilpeläinen; Jonna K Tyni; Maija K Lahtela-Kakkonen; Tony S Eteläinen; Timo T Myöhänen; Erik A A Wallén
Journal:  ACS Med Chem Lett       Date:  2019-11-11       Impact factor: 4.345

4.  MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition.

Authors:  Daniela Macconi; Susanna Tomasoni; Paola Romagnani; Piera Trionfini; Fabio Sangalli; Benedetta Mazzinghi; Paola Rizzo; Elena Lazzeri; Mauro Abbate; Giuseppe Remuzzi; Ariela Benigni
Journal:  J Am Soc Nephrol       Date:  2012-07-19       Impact factor: 10.121

5.  Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner.

Authors:  T T Myöhänen; J Tenorio-Laranga; B Jokinen; R Vázquez-Sánchez; M J Moreno-Baylach; J A García-Horsman; P T Männistö
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

6.  Prolyl oligopeptidase enhances α-synuclein dimerization via direct protein-protein interaction.

Authors:  Mari H Savolainen; Xu Yan; Timo T Myöhänen; Henri J Huttunen
Journal:  J Biol Chem       Date:  2015-01-02       Impact factor: 5.157

7.  Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin.

Authors:  K N Lee; K W Jackson; V J Christiansen; E K Dolence; P A McKee
Journal:  J Thromb Haemost       Date:  2011-05       Impact factor: 5.824

8.  Importance of membrane-bound catechol-O-methyltransferase in L-DOPA metabolism: a pharmacokinetic study in two types of Comt gene modified mice.

Authors:  M Käenmäki; A Tammimäki; J A Garcia-Horsman; T Myöhänen; N Schendzielorz; M Karayiorgou; J A Gogos; P T Männistö
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

9.  Distribution of prolyl oligopeptidase in human peripheral tissues and in ovarian and colorectal tumors.

Authors:  Timo T Myöhänen; Elisa Pyykkö; Pekka T Männistö; Olli Carpen
Journal:  J Histochem Cytochem       Date:  2012-06-26       Impact factor: 2.479

10.  The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse.

Authors:  Mari H Savolainen; Christopher T Richie; Brandon K Harvey; Pekka T Männistö; Kathleen A Maguire-Zeiss; Timo T Myöhänen
Journal:  Neurobiol Dis       Date:  2014-04-16       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.